BORDI, Cesare
 Distribuzione geografica
Continente #
NA - Nord America 2.232
EU - Europa 1.459
AS - Asia 967
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
SA - Sud America 2
OC - Oceania 1
Totale 4.671
Nazione #
US - Stati Uniti d'America 2.182
CN - Cina 591
IE - Irlanda 338
UA - Ucraina 285
SE - Svezia 274
FI - Finlandia 255
SG - Singapore 242
DE - Germania 149
TR - Turchia 71
GB - Regno Unito 57
IT - Italia 54
IN - India 53
CA - Canada 50
BE - Belgio 22
EU - Europa 6
FR - Francia 6
IR - Iran 5
LT - Lituania 5
NL - Olanda 5
RU - Federazione Russa 3
CI - Costa d'Avorio 2
EG - Egitto 2
PE - Perù 2
TW - Taiwan 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
HU - Ungheria 1
LK - Sri Lanka 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 4.671
Città #
Chandler 375
Dublin 338
Jacksonville 315
Santa Clara 225
Singapore 203
Beijing 140
Dearborn 138
Ashburn 120
Ann Arbor 116
Boardman 95
Nanjing 83
San Mateo 69
Princeton 68
Izmir 67
Shanghai 58
Pune 48
Wilmington 45
Toronto 43
Woodbridge 35
Kunming 33
Helsinki 32
Nanchang 30
Jinan 25
Shenyang 24
Los Angeles 23
Brussels 22
New York 22
Parma 21
Hebei 19
Hefei 18
Tianjin 18
Jiaxing 15
Changsha 14
Hangzhou 13
Guangzhou 12
Auburn Hills 11
Bremen 10
Des Moines 9
Haikou 9
Chengdu 7
Dallas 7
Lanzhou 6
Norwalk 6
Ottawa 6
Wenzhou 6
Zhengzhou 6
Ningbo 5
Seattle 5
Borås 4
Fremont 4
Fuzhou 4
Houston 4
London 4
Rio Saliceto 4
Taizhou 4
Andover 3
Baotou 3
Falls Church 3
Kocaeli 3
Rockville 3
Abidjan 2
Cairo 2
Clifton 2
Düsseldorf 2
Kashan 2
Leawood 2
Lima 2
Luzzi 2
Marseille 2
Sacramento 2
Taiyuan 2
Xian 2
Amsterdam 1
Augusta 1
Bangalore 1
Budapest 1
Changchun 1
Chaoyang 1
Chiayi County 1
Chicago 1
Chongqing 1
Colombo 1
Copenhagen 1
Cormeilles-en-Parisis 1
Gatchina 1
Grafing 1
Harbin 1
Henderson 1
Hong Kong 1
Huzhou 1
Las Vegas 1
Madrid 1
Medolla 1
Melbourne 1
Montréal 1
Mumbai 1
Munich 1
New Taipei City 1
North Charleston 1
Omsk 1
Totale 3.110
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 119
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 102
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 102
Classification of gastric endocrine cells at the light and electron microscopical levels 97
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 95
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 93
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 92
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 88
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 87
Endocrine tumors of the gastrointestinal system 86
È L’ANGIOGENESI UN FATTORE PROGNOSTICO NEGLI ADENOCARCINOMI DEL COLON-RETTO IN STADIO B DI DUKES? 85
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. 85
Loss of heterozygosity at 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome 82
Pleomorph poorly differentiated endocrine carcinoma of the rectum 82
Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding 82
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. 82
Poorly differentiated endocrine carcinoma 80
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 80
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 79
Classification of neuroendocrine tumours 79
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 79
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 79
Biclonality of gastric lymphomas 76
Aetiology, molecular pathogenesis and genetics 75
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy 74
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 74
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 73
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 72
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture 72
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 72
Criteria for malignancy in gastrointestinal endocrine tumors 71
AMPULLARY ADENOCARCINOMA IN VON RECKLINGHAUSEN’S DISEASE. CASE REPORT AND LITERATURE REVIEW. 71
Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case 70
Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. 70
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I 70
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 70
Multiple endocrine neoplasia type 1 68
Heterotopic mesenteric ossification (Intraabdominal myositis ossificans): Report of five cases 68
Non-functioning tumours and microadenomas 66
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 66
Different patterns of 11q allelic losses in digestive endocrine tumors 66
Highlights on biology of endocrine tumours of the gut and pancreas 65
Pancreatic endocrine tumours: Introduction 64
Gastric neuroendocrine neoplasms: tumor clonality and malignancy associated large X-chromosomal deletions 64
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases 61
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas 60
Multiple endocrine neoplasia (MEN)-associated tumours 60
Gastrinomas 58
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms 57
Mixed exocrine-endocrine carcinomas 56
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: Associations with clinicopathological and molecular features 56
Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection 55
Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis 54
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 54
Prognostic factors in gastrointestinal endocrine tumors 53
PTU-064 Identification of Syne 1 and Foxe 1 Hypermethylation to improve diagnosis and amangement of colorectal neoplasia in Inflammatory Bowel disease 53
Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up 51
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 51
Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool 49
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma 49
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. 48
Hypergastrinemia and gastric enterochromaffin-like cells 46
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization 45
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 42
The normal endocrine cell of the gut. Changing concepts and new evidences 39
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p 38
Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets 35
Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids 35
Totale 4.677
Categoria #
all - tutte 16.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.396


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020505 0 0 0 0 0 98 114 20 90 97 14 72
2020/2021465 4 65 64 7 63 4 62 4 104 14 69 5
2021/2022367 11 2 2 26 13 7 48 64 17 31 46 100
2022/20231.269 147 135 55 107 114 141 16 73 428 4 37 12
2023/2024414 29 41 5 2 37 153 22 29 5 21 24 46
2024/2025592 18 78 91 57 170 178 0 0 0 0 0 0
Totale 4.677